Skip to main content
SpringerLink
Log in

Gynecologic Oncological Surgical Emergencies

  • Chapter
  • First Online:
Oncologic Surgical Emergencies

Part of the book series: Hot Topics in Acute Care Surgery and Trauma ((HTACST))

  • 200 Accesses

Abstract

Gynecologic oncology presents a wide range of scenarios of surgical emergencies, as it comprehends various organs and different tumoral extension. The diffusion to other organs and the modality of spread are characterized not only by the organ of origin (ovary, uterus, cervix), but also by the histology. Therefore, a thorough knowledge of this chapter of oncology is needed to choose the correct management strategy in the emergency setting.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Buskwofie A, David-West G, Clare CA. A review of cervical cancer: incidence and disparities. J Natl Med Assoc. 2020;112(2):229–32.

    PubMed  Google Scholar 

  2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

    Article  PubMed  Google Scholar 

  3. Koh WJ, Greer BE, Abu-Rustum NR, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Dizon DS, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Higgins S, Huh WK, Lurain JR 3rd, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Valea FA, Wyse E, Yashar CM, McMillian N, Scavone J. Vulvar cancer, version 1.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2017;15(1):92–120.

    Article  Google Scholar 

  4. Adams TS, Rogers LJ, Cuello MA. Cancer of the vagina: 2021 update. Int J Gynaecol Obstet. 2021;155(Suppl 1):19–27.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Roett MA, Evans P. Ovarian cancer: an overview. Am Fam Physician. 2009;80(6):609–16.

    PubMed  Google Scholar 

  6. Yi M, Li T, Niu M, et al. Epidemiological trends of women’s cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study. Biomark Res. 2021;9:55.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Bosscher MR, van Leeuwen BL, Hoekstra HJ. Surgical emergencies in oncology. Cancer Treat Rev. 2014;40(8):1028–36.

    Article  CAS  PubMed  Google Scholar 

  8. Ramirez PT, Levenback C, Burke TW, Eifel P, Wolf JK, Gershenson DM. Sigmoid perforation following radiation therapy in patients with cervical cancer. Gynecol Oncol. 2001;82(1):150–5.

    Article  CAS  PubMed  Google Scholar 

  9. Yamashita H, Nakagawa K, Tago M, Igaki H, Shiraishi K, Nakamura N, Sasano N, Yamakawa S, Ohtomo K. Small bowel perforation without tumor recurrence after radiotherapy for cervical carcinoma: report of seven cases. J Obstet Gynaecol Res. 2006;32(2):235–42.

    Article  PubMed  Google Scholar 

  10. Richardson DL, Backes FJ, Hurt JD, Seamon LG, Copeland LJ, Fowler JM, Cohn DE, O’Malley DM. Which factors predict bowel complications in patients with recurrent epithelial ovarian cancer being treated with bevacizumab? Gynecol Oncol. 2010;118:47–51.

    Article  CAS  PubMed  Google Scholar 

  11. Sasaki A, Harano K, Kogawa T, Matsubara N, Naito Y, Hosono A, Mukai H, Yoshino T, Mukohara T. Intestinal perforation due to neutropenic enterocolitis in a patient treated with bevacizumab for ovarian cancer. Case Rep Oncol Med. 2020;2020:7231358.

    PubMed  PubMed Central  Google Scholar 

  12. Hapani S, Chu D, Wu S. Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis. Lancet Oncol. 2009;10:559–68.

    Article  CAS  PubMed  Google Scholar 

  13. Cannistra SA, Matulonis UA, Penson RT, Hambleton J, Dupont J, Mackey H, Douglas J, Burger RA, Armstrong D, Wenham R, McGuire W. Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer. J Clin Oncol. 2007;25:5180–6.

    Article  CAS  PubMed  Google Scholar 

  14. Garg G, Massad LS, Pourabolghasem S, Zhou G, Powell MA, Thaker PH, Hagemann AR, Wilkinson-Ryan I, Mutch DG. Intestinal perforation in gynecologic oncology: do all patients benefit from surgical management? Gynecol Oncol. 2013;129(3):538–43.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Garg G, Pourbolghasem S, Zhou G, Powell MA, Thaker PH, Hagemann AR, Wilkinson-Ryan I, Massad LS, Mutch DG. Factors influencing survival in gynecologic oncology patients diagnosed with intestinal perforation and pneumatosis intestinalis. Cancer Res. 2013;73(8 Supplement):1378.

    Article  Google Scholar 

  16. Tuca A, Guell E, Martinez-Losada E, Codorniu N. Malignant bowel obstruction in advanced cancer patients: epidemiology, management, and factors influencing spontaneous resolution. Cancer Manag Res. 2012;4:159–69.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Bais JMJ, Schilthuis MS, Slors JFM, et al. Intestinal obstruction in patients with advanced ovarian cancer. Int J Gynecol Cancer. 1995;5:346–50.

    Article  PubMed  Google Scholar 

  18. Camignani CP, Sugarbaker TA, Bromley CM, et al. Intraperitoneal cancer dissemination: mechanisms of the patterns of spread. Cancer Metastasis Rev. 2003;22:465–72.

    Article  Google Scholar 

  19. Dvoretsky PM, Richards KA, Angel C, et al. Distribution of disease at autopsy in 100 women with ovarian cancer. Human Pathol. 1988;19:57–63.

    Article  CAS  Google Scholar 

  20. Jatoi A, Podratz KC, Gill P, Hartmann LC. Pathophysiology and palliation of inoperable bowel obstruction in patients with ovarian cancer. J Support Oncol. 2004;2:323–37.

    PubMed  Google Scholar 

  21. Kucukmetin A, Naik R, Galaal K, Bryant A, Dickinson HO. Palliative surgery versus medical management for bowel obstruction in ovarian cancer. Cochrane Database Syst Rev. 2010;2010(7):CD007792.

    PubMed  PubMed Central  Google Scholar 

  22. Kolomainen DF, Barton DP. Surgical management of bowel obstruction in gynaecological malignancies. Curr Opin Support Palliat Care. 2011;5(1):55–9.

    Article  PubMed  Google Scholar 

  23. Feuer DJ, Broadley KE, Shepherd JH, et al. Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer. Gynecol Oncol. 1999;75:313–22.

    Article  CAS  PubMed  Google Scholar 

  24. Tunca JC, Buchler DA, Mack EA, Ruzicka FF, Crowley JJ, Carr WF. The management of ovarian-cancer-caused bowel obstruction. Gynecol Oncol. 1981;12(2 Pt 1):186–92.

    Article  CAS  PubMed  Google Scholar 

  25. Paul Olson TJ, Pinkerton C, Brasel KJ, Schwarze ML. Palliative surgery for malignant bowel obstruction from Carcinomatosis: a systematic review. JAMA Surg. 2014;149:383.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Jin M, Shen F, Li M, Chen Y. Palliative treatment for bowel obstruction in ovarian cancer: a meta-analysis. Arch Gynecol Obstet. 2020;302:241–8.

    Article  PubMed  Google Scholar 

  27. Armbrust R, Chekerov R, Sander S, Biebl M, Chopra S, Krell J, Rinne N, Nixon K, Fotopoulou C, Sehouli J. Surgery due to mechanical bowel obstruction in relapsed ovarian cancer: clinical and surgical results of a bicentric analysis of 87 patients. Arch Gynecol Obstet. 2021;305(4):963–8. https://doi.org/10.1007/s00404-021-06237-x.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Shrivastava S, Mahantshetty U, Engineer R, et al. Treatment and outcome in cancer cervix patients treated between 1979 and 1994: a single institutional experience. J Cancer Res Ther. 2013;9:672–9.

    Article  PubMed  Google Scholar 

  29. Eleje GU, Eke AC, Igberase GO, et al. Palliative interventions for controlling vaginal bleeding in advanced cervical cancer. Cochrane Database Syst Rev. 2015;5:CD011000.

    Google Scholar 

  30. Yanazume Y, Douzono H, Yanazume S, Iio K, Kojima N, Mukaihara K, et al. Clinical usefulness of Mohs’ paste for genital bleeding from the uterine cervix or vaginal stump in gynecologic cancer. J Palliat Med. 2013;16(2):193–7.

    Article  PubMed  Google Scholar 

  31. Pisco JM, Martins JM, Correia MG. Internal iliac artery: embolization to control hemorrhage from pelvic neoplasms. Radiology. 1989;172:337–9.

    Article  CAS  PubMed  Google Scholar 

  32. Çaypınar SS, Güraslan H, Şentürk B, Cengiz H, Yaşar L. Salvage therapy in acute life-threatening vaginal bleeding of cervical cancer: hypogastric artery embolization. Taiwan J Obstet Gynecol. 2016;55(4):607–8.

    Article  PubMed  Google Scholar 

  33. Siegel P, Mengert WF. Internal iliac artery ligation in obstetrics and gynecology. JAMA. 1961;178:1059–62.

    Article  CAS  PubMed  Google Scholar 

  34. Kelly H. Ligation of both internal iliac arteries for hemorrhage in hysterectomy for carcinoma uteri. Bull John Hopkins Hosp. 1984;5:53.

    Google Scholar 

  35. Chitragari G, Schlosser FJ, Ochoa Chaar CI, Sumpio BE. Consequences of hypogastric artery ligation, embolization, or coverage. J Vasc Surg. 2015;62(5):1340–7.el.

    Article  PubMed  Google Scholar 

  36. Popovici LR, Ciulcu A, Dorobat B, Dumitraşcu M, Horhoianu VV, Cirstoiu M. Therapeutic approaches in pelvic bleeding of neoplastic origin. J Med Life. 2014;7(3):391–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Johnstone C, Rich SE. Bleeding in cancer patients and its treatment: a review. Ann Palliat Med. 2018;7(2):265–73.

    Article  PubMed  Google Scholar 

  38. Spanos WJ Jr, Wasserman T, Meoz R, et al. Palliation of advanced pelvic malignant disease with large fraction pelvic radiation and misonidazole: final report of RTOG phase I/II study. Int J Radiat Oncol Biol Phys. 1987;13:1479–82.

    Article  PubMed  Google Scholar 

  39. Yan J, Milosevic M, Fyles A, et al. A hypofractionated radiotherapy regimen (0-7-21) for advanced gynaecological cancer patients. Clin Oncol (R Coll Radiol). 2011;23:476–81.

    Article  PubMed  Google Scholar 

  40. Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer. Lancet. 2016;387(10023):1094–108.

    Article  PubMed  Google Scholar 

  41. Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, Ledermann J, Bosse T, Chargari C, Fagotti A, Fotopoulou C, Martin AG, Lax S, Lorusso D, Marth C, Morice P, Nout RA, O’Donnell D, Querleu D, Raspollini MR, Sehouli J, Sturdza A, Taylor A, Westermann A, Wimberger P, Colombo N, Planchamp F, Creutzberg CL. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Radiother Oncol. 2021;154:327–53.

    Article  PubMed  Google Scholar 

  42. Roberts ME, Aynardi JT, Chu CS. Uterine leiomyosarcoma: a review of the literature and update on management options. Gynecol Oncol. 2018;151(3):562–72.

    Article  PubMed  Google Scholar 

  43. Bankhead CR, Kehoe ST, Austoker J. Symptoms associated with diagnosis of ovarian cancer: a systematic review. BJOG. 2005;112(7):857–65.

    Article  PubMed  Google Scholar 

  44. Urbano-Ruiz A, Soares JM Jr, da Motta EV, Granuzzo P, Julião CC, Baracat EC. When to perform palliative surgery in the treatment of ovarian cancer: a brief review. Eur J Gynaecol Oncol. 2013;34(6):532–4.

    CAS  PubMed  Google Scholar 

  45. Casal Rodriguez AX, Sanchez Trigo S, Ferreira Gonzalez L, Brage GS. Hemoperitoneum due to spontaneous rupture of ovarian adenocarcinoma. Emerg Radiol. 2011;18(3):267–9.

    Article  PubMed  Google Scholar 

  46. Lee WL, Yuan CC, Lai CR, Wang PH. Hemoperitoneum is an initial presentation of recurrent granulosa cell tumors of the ovary. Jpn J Clin Oncol. 1999;29(10):509–12.

    Article  CAS  PubMed  Google Scholar 

  47. Principles and Practice of Oncology 11th edition (July 2018): by Vincent T. Devita (Editor), Samuel Hellman, Steven A. Rosenberg (Editor) By Lippincott Williams & Wilkins Publishers.

    Google Scholar 

  48. Zon RT, Nichols C, Einhorn LH. Management strategies and outcomes of germ cell tumor patients with very high human chorionic gonadotropin levels. J Clin Oncol. 1998;16:1294–7.

    Article  CAS  PubMed  Google Scholar 

  49. Peng H, Li L, Bi Y. Successful management of nongestational ovarian choriocarcinoma complicated with choriocarcinoma syndrome: a case report and a literature review. Curr Probl Cancer. 2020;44(4):100539.

    Article  PubMed  Google Scholar 

  50. Rejlekova K, Cursano MC, De Giorgi U, Mego M. Severe complications in testicular germ cell tumors: the Choriocarcinoma syndrome. Front Endocrinol (Lausanne). 2019;10:218.

    Article  PubMed  Google Scholar 

  51. Gupta R, Jenison EL. A rare case of carcinosarcoma of the fallopian tube presenting with torsion, rupture and hemoperitoneum. Gynecol Oncol Case Rep. 2011;2(1):4–5.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Hapani S, Sher A, Chu D, Wu S. Increased risk of serious hemorrhage with bevacizumab in cancer patients: a meta-analysis. Oncology. 2010;79(1–2):27–38.

    Article  CAS  PubMed  Google Scholar 

  53. Iwasa-Inoue N, Nomura H, Kataoka F, Chiyoda T, Yoshihama T, Nanki Y, Sakai K, Kobayashi Y, Yamagami W, Morisada T, Hirasawa A, Aoki D. Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy followed by interval debulking surgery for advanced ovarian, fallopian tube, and primary peritoneal cancer patients. Int J Clin Oncol. 2021;27(2):441–7.

    Article  PubMed  Google Scholar 

  54. Turco LC, Ferrandina G, Vargiu V, Cappuccio S, Fagotti A, Sallustio G, Scambia G, Cosentino F. Extreme complications related to bevacizumab use in the treatment of ovarian cancer: a case series from a III level referral Centre and review of the literature. Ann Transl Med. 2020;8(24):1687.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Huang C, Hong MK, Ding DC. A review of ovary torsion. Ci Ji Yi Xue Za Zhi. 2017;29(3):143–7.

    PubMed  Google Scholar 

  56. Lee CH, Raman S, Sivanesaratnam V. Torsion of ovarian tumors: a clinicopathological study. Int J Gynaecol Obstet. 1989;28(1):21–5.

    Article  CAS  PubMed  Google Scholar 

  57. Bah A, Diakite I, Maiga A, Sidibe BY, Konaté M, Saye Z, Kelly B, Koné T, Konate S, Doumbia AA, Traore B, Karembe B, Diakite ML, Traoré AA, Diarra A, Mangane MI, Almeimoune AH, Dembélé BT, Traoré A, Kanté L, Togo AP. Torsion of ovarian tumor in the elderly: about a case. Surg Sci. 2020;11:69–73.

    Article  Google Scholar 

  58. Toba N, Takahashi T, Ota K, Takanashi A, Iizawa Y, Endo Y, Furukawa S, Soeda S, Watanabe T, Mizunuma H, Fujimori K, Takeichi K. Malignant transformation arising from mature cystic teratoma of the ovary presenting as ovarian torsion: a case report and literature review. Fukushima J Med Sci. 2020;66(1):44–52.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Salakos N, Bakalianou K, Deligeoroglou E, Kondi-Pafiti A, Papadias K, Creatsas G. Endometrial carcinoma presenting as hematometra: clinicopathological study of a rare case and literature review. Eur J Gynaecol Oncol. 2007;28(3):239–40.

    CAS  PubMed  Google Scholar 

  60. Patel K, Foster NR, Kumar A, et al. Hydronephrosis in patients with cervical cancer: an assessment of morbidity and survival. Support Care Cancer. 2015;23:1303–9.

    Article  PubMed  Google Scholar 

  61. Perri T, Meller E, Ben-Baruch G, Inbar Y, Apter S, Heyman L, Dotan Z, Korach J. Palliative urinary diversion in patients with malignant ureteric obstruction due to gynaecological cancer. BMJ Support Palliat Care. 2012;12(e6):e855–61.

    Article  Google Scholar 

  62. Geisler JP, Perry RW, Ayres GM, Holland TF 3rd, Melton ME, Geisler HE. Ovarian cancer causing upper and lower urinary tract obstruction. Eur J Gynaecol Oncol. 1994;15(5):343–4.

    CAS  PubMed  Google Scholar 

  63. Wit E, Horenblas S. Urological complications after treatment of cervical cancer. Nat Rev Urol. 2014;11:110–7.

    Article  PubMed  Google Scholar 

  64. Kietpeerakool C, Rattanakanokchai S, Jampathong N, Srisomboon J, Lumbiganon P. Management of drainage for malignant ascites in gynaecological cancer. Cochrane Database Syst Rev. 2019;12(12):CD007794.

    PubMed  Google Scholar 

  65. Meyer L, Suidan R, Sun C, Westin S, Coleman RL, Mills GB. The management of malignant ascites and impact on quality of life outcomes in women with ovarian cancer. Expert Rev Qual Life Cancer Care. 2016;1(3):231–8.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Oncologic Gynecology, IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy

    Pier Andrea De Iaco

Authors
  1. Pier Andrea De Iaco
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pier Andrea De Iaco .

Editor information

Editors and Affiliations

  1. Emergency Surgery Dept., Parma University Hospital, Parma, Italy

    Antonio Tarasconi

  2. Oncology Dept., Parma University Hospital, Parma, Italy

    Simona Bui

  3. Digestive Surgery Dept, Ctr. Hosp. Univ. Grenoble Alpes, La Tronche, France

    Mircea Chirica

  4. Hepato-gastroenterology and Digestive oncology Dept., Grenoble-Alpes University Hospital, Grenoble, France

    Gaël Roth

  5. Department of Surgery, University of California, Irvine, Orange, CA, USA

    Jeffry Nahmias

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

De Iaco, P.A. (2023). Gynecologic Oncological Surgical Emergencies. In: Tarasconi, A., Bui, S., Chirica, M., Roth, G., Nahmias, J. (eds) Oncologic Surgical Emergencies. Hot Topics in Acute Care Surgery and Trauma. Springer, Cham. https://doi.org/10.1007/978-3-031-36860-8_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-36860-8_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-36859-2

  • Online ISBN: 978-3-031-36860-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation